| Filing Date | T Date | Ticker | Sector | Ind | Industry | Owner | oSt | Rel | Title | T | TVal | Price | L | Qty | oc | Own | H | r2y | r1y | r6m | r3m | r6w | r3w | r7d | r3d | f1d | f1w | f1m | f3m | f6m | f1y | 
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12/6/11 10:44 | 11/28/11 | SLXCF | Health | Drug | Pharmaceutical Preparations | Riehl Peter Roy | A6 | T | S.m | -27 | 0.5400 | 0 | -50 | -1 | 6,499 | D | |||||||||||||||
| 12/1/11 10:44 | 11/9/11 | SLXCF | Health | Drug | Pharmaceutical Preparations | Riehl Peter Roy | A6 | T | S.m | -11 | 0.5000 | 0 | -22 | -1 | 3,287 | D | |||||||||||||||
| 10/26/11 14:49 | 10/18/11 | SLXCF | Health | Drug | Pharmaceutical Preparations | Riehl Peter Roy | A6 | T | S.m | -14 | 0.4627 | 0 | -30 | -1 | 3,308 | D | |||||||||||||||
| 9/27/11 12:15 | 4/5/11 | SLXCF | Health | Drug | Pharmaceutical Preparations | Riehl Peter Roy | A6 | T | S.am | -85 | 0.6185 | 0 | -137 | -4 | 3,338 | D | |||||||||||||||
| 8/31/10 16:17 | 8/26/10 | SLXCF | Health | Drug | Pharmaceutical Preparations | Goldman Steven Harold | A6 | D | S | 0 | 0.8600 | 0 | 0 | 0 | 464 | D | |||||||||||||||
| 7/2/10 11:34 | 6/30/10 | SLXCF | Health | Drug | Pharmaceutical Preparations | Clarke Janice Marie | A6 | O | CFO | S.d | -20 | 0.9000 | 0 | -22 | -19 | 90 | M | ||||||||||||||
| 4/4/07 13:37 | 6/20/06 | SLXCF | Health | Drug | Pharmaceutical Preparations | Rosenkrantz David Aubrey | A6 | D | S | -10 | 0.8400 | 0 | -12 | -11 | 98 | I | 
| D | Derivative transaction in filing (usually option exercise) | 
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price | 
| A | Amended filing | 
| E | Error detected in filing | 
| S - Sale | Sale of securities on an exchange or to another person | 
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) | 
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company | 
| P - Purchase | Purchase of securities on an exchange or from another person |